Aug 12 |
Why Eli Lilly Is a Buy After Earnings. The Stock Got an Upgrade.
|
Aug 12 |
Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest
|
Aug 12 |
Eli Lilly has 'a good story': Deutsche Bank analyst on upgrade
|
Aug 12 |
Eli Lilly Q2 Earnings: Thanks To Tirzepatide, $1 Trillion Valuation Now In Sight
|
Aug 12 |
5 ETFs to Make the Most of Eli Lilly's Strength
|
Aug 12 |
Eli Lilly Taps Blue-Chip Bond Market to Fund Morphic Acquisition
|
Aug 12 |
These Stocks Are Moving the Most Today: KeyCorp, Hawaiian Electric, Barrick Gold, Starbucks, and More
|
Aug 12 |
Deutsche Bank calls Eli Lilly a ‘high growth unicorn’ in upgrade to Buy
|
Aug 12 |
Jim Cramer Considers Eli Lilly and Company (LLY) a ‘Best of Breed’ Stock
|
Aug 12 |
Eli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
|